• Personalized Medicine in Action
• Pfizer
• caBIG^®
• HPCGG

Personalized Medicine in Action

Read more about how researchers and clinicians are utilizing the most cutting-edge technologies and innovative research methods to make personalized medicine a reality from bench to bedside and back again.

• Pfizer
  Through a partnership with a diagnostic company, Pfizer was able to develop an HIV drug targeted to a specific group of patients, thus launching the first new class of HIV medications in over a decade. Learn more
• cancer Biomedical Informatics Grid^® (caBIG^®)
  The National Cancer Institute's caBIG^® enables the collection, analysis, and exchange of data along the research pathway from laboratory bench to patient bedside, leveraging the power of modern information technologies in the fight against cancer. Learn more
• Harvard Medical School-Partners HealthCare Center for Genetics and Genomics (HPCGG)
  HPCGG, now the Partners HealthCare Center for Personalized Genetic Medicine, pioneered "bench-to-bedside-to-bench" studies to unlock the mystery of hypertrophic cardiomyopathy, a deadly heart disease. Learn more